Technical Analysis for FPRX - Five Prime Therapeutics, Inc.

Grade Last Price % Change Price Change
C 22.18 -0.58% -0.13
FPRX closed down 4.78 percent on Tuesday, March 2, 2021, on 46 percent of normal volume.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down
Historical FPRX trend table...

Date Alert Name Type % Chg
Wide Bands Range Expansion -0.58%
Wide Bands Range Expansion -5.34%
Slingshot Bullish Bullish Swing Setup -0.22%
Wide Bands Range Expansion -0.22%
Overbought Stochastic Strength -0.22%
New 52 Week High Strength -3.90%
Upper Bollinger Band Walk Strength -3.90%
Outside Day Range Expansion -3.90%
Wide Bands Range Expansion -3.90%
Overbought Stochastic Strength -3.90%
Older End-of-Day Signals for FPRX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Down 2 % 15 minutes ago
Down 1% 15 minutes ago
Fell Below Previous Day's Low 15 minutes ago
Down 5% about 21 hours ago
60 Minute Opening Range Breakdown about 22 hours ago
View Earlier Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Five Prime Therapeutics, Inc. Description

Five Prime Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of protein therapeutics that block cancer and inflammatory disease processes. The company's product candidates include FP-1039/GSK3052230, a protein therapeutic is in PhaseIb clinical trials for trapping and neutralizing cancer-promoting fibroblast growth factors (FGFs) involved in cancer cell proliferation and new blood vessel formation; FPA008, an antibody that inhibits colony stimulating factor-1 receptor; and FPA144 is an antibody for inhibiting FGF receptor 2b, as well as to treat patients with gastric cancer and potentially other solid tumors. It has collaboration and license agreements with GlaxoSmithKline LLC, Glaxo Group Limited, GSK-HGS, Pfizer Inc., and UCB Pharma S.A. The company was founded in 2001 and is headquartered in South San Francisco, California.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Cancer Life Sciences Solid Tumors Monoclonal Antibodies Inflammatory Disease Cancer Cell Tyrosine Kinase Receptors Glaxosmithkline Fibroblast Growth Factor Growth Factors Gastric Cancer Fibroblast Growth Factor Receptor 2

Is FPRX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 26.25
52 Week Low 1.75
Average Volume 917,434
200-Day Moving Average 10.18
50-Day Moving Average 18.65
20-Day Moving Average 21.27
10-Day Moving Average 23.01
Average True Range 1.74
ADX 29.48
+DI 28.48
-DI 15.48
Chandelier Exit (Long, 3 ATRs ) 21.03
Chandelier Exit (Short, 3 ATRs ) 20.74
Upper Bollinger Band 25.44
Lower Bollinger Band 17.10
Percent B (%b) 0.62
BandWidth 39.20
MACD Line 1.58
MACD Signal Line 1.55
MACD Histogram 0.0293
Fundamentals Value
Market Cap 1.03 Billion
Num Shares 46.3 Million
EPS -4.49
Price-to-Earnings (P/E) Ratio -4.97
Price-to-Sales 35.65
Price-to-Book 8.39
PEG Ratio 0.14
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 24.43
Resistance 3 (R3) 24.59 24.04 24.07
Resistance 2 (R2) 24.04 23.50 23.96 23.96
Resistance 1 (R1) 23.17 23.17 22.90 23.02 23.84
Pivot Point 22.63 22.63 22.49 22.55 22.63
Support 1 (S1) 21.76 22.09 21.49 21.60 20.78
Support 2 (S2) 21.22 21.75 21.14 20.66
Support 3 (S3) 20.35 21.22 20.55
Support 4 (S4) 20.19